The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score 4.23 — safe zoneOK
- Earnings-manipulation signal · Beneish M -2.28 — no flag raisedOK
- Earnings quality 91/100 — accruals in line with cashOK
Where the revenue comes from
Fiscal 2025, as Merck & Co., Inc. reports it. History and quarterly detail are in the app.
- Pharmaceutical$58.1B
- Animal Health$6.4B
Leadership changes
From Merck & Co., Inc.'s own filings, the day they're filed.
- Peter C. Wendell · Directors · departureeff. 2024-02-15
- Rita Karachun · President · departureeff. 2023-12-04
Latest filings
- 10-Q · Quarterly report2026-08-07
- 8-K · Company announcement2026-08-04
- 8-K · Company announcement2026-05-28
- 8-K · Company announcement2026-05-22
- 10-Q · Quarterly report2026-05-04
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Merck & Co., Inc., every answer cited to the official filings🔒
- The Intelligence Brief — added when Merck & Co., Inc.'s brief passes our SEC-figure check🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.